Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7

J. Zhang, W.-H. Gong, Y. Li, H.-Y. Zhang, C.-X. Zhang

Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

 

---

• Oncology

Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Hsa-miR-337 inhibits non-small cell lung cancer cell invasion and migration by targeting TCF7, by J. Zhang, W.-H. Gong, Y. Li, H.-Y. Zhang, C.-X. Zhang, published in Eur Rev Med Pharmacol Sci 2019; 23 (15): 6548-6553–DOI: 10.26355/eurrev_201908_18540–PMID: 31378895” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/18540

Free PDF Download